Will The Rally Continue? Heading Higher? TapImmune Inc. (NASDAQ:MRKR)

TapImmune Inc. (NASDAQ:MRKR) stock end the session high on Friday.

Market Action

MRKR stock gained over 9.90% to close at $2.77. More than 4.79 million shares traded hands for the session, compared to its 30-day average volume of 3.97 million shares. The stock opened at $2.57 and moved within a range of $2.5100 – 2.8780 on Friday.

MRKR Business Description

Marker Therapeutics, Inc., a clinical stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. Its MultiTAA-specific T cell technology is based on the expansion of non-engineered tumor-specific T cells that recognize tumor associated antigens and kill tumor cells expressing those targets.

The company’s MultiTAA-specific T cell therapies include autologous T cells for the treatment of lymphoma, multiple myeloma, and various solid tumors; and allogeneic T cells for the treatment of acute myeloid leukemia and acute lymphoblastic leukemia. It is also developing TPIV100/110, which is in Phase II clinical trial for the treatment of breast cancer; and TPIV200 that is in Phase II clinical trial for the treatment of breast and ovarian cancers. Marker Therapeutics, Inc. is headquartered in Houston, Texas.

Trader Notes

Share Information

SHARE FLOAT (%)56.64 M (68.23%)

Recent Stock Performance

5-DAY PERF.+23.66%
1-MONTH PERF.+33.82%
3-MONTH PERF.-2.46%
6-MONTH PERF.+81.05%
YTD PERF.+91.03%
1-YEAR PERF.-0.72%

Moving Averages

+/- EMA(20)2.39 (+15.90%)
+/- SMA(50)2.27 (+22.03%)
+/- SMA(200)1.94 (+42.78%)

Pivot Points

NameS3S2S1Pivot PointsR1R2R3

Technical Indicators

CCI20165.2211BuyChaikin Money Flow0.0672Buy
MACD0.0440BuyMoney Flow Index55.1320Buy
STOCH (14,3)86.9048OverBoughtSTOCH RSI1.0000OverBought
UO55.5547BuyWilliams %R-13.0952OverBought

Related Posts

About The Author